RE:No One DisputesFront and center. thanks for the post mate
sanspeine wrote: No one disputes forward guidance.
No one disputes that AMco was not a transformative acquisition
No one disputes the growth scenario for the next 5 years.
No one disputes that cash flows will be substantively above debt and interest repayments
No one disputes that being equity conservative, potential for future equity raises are robust.
No one disputes that 224 drugs represents one of the largest suite of drugs held by any pharma of any size.
So why is Concordia trading at just 1/3 of its recent former high?
Its a sideswipe caused by poorly performing US hedge funds selecting the best performing sector and issueing or paying for the issue of distorting research reports that spooked the markets and made successful their shorting game plan.
Havent anyone noticed that not a single accusation has been proven nor will one ever be proven.
We have just been taken for a ride.
Very soon, the sharks will move on and this sector will return to its normal rating as the best investment performing niche.
Afterall, other than perhaps technology, what else has such fundamentals.
This coming week we shall see the beginning of the return to normality for healthcare and pharma stocks